Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Acta Tropica|May 30, 2006
Detection of relapsing fever in human blood samples from Israel using PCR targeting the glycerophosphodiester phosphodiesterase (GlpQ) geneTamar Halperin, Nadav Orr, Regev Cohen, et al.
Human Vaccines & Immunotherapeutics|May 10, 2019
Serum IgG antibodies to <i>Shigella</i> lipopolysaccharide antigens - a correlate of protection against shigellosisDani Cohen, Shiri Meron-Sudai, Anya Bialik, et al.
The Journal of Infectious Diseases|October 13, 2009
Incidence, characteristics, and economic burden of rotavirus gastroenteritis associated with hospitalization of israeli children <5 years of age, 2007-2008Khitam Muhsen, Lester Shulman, Uri Rubinstein, et al.
JAMA Internal Medicine|June 23, 2022
Association of Receipt of the Fourth BNT162b2 Dose With Omicron Infection and COVID-19 Hospitalizations Among Residents of Long-term Care FacilitiesKhitam Muhsen, Nimrod Maimon, Amiel Yaron Mizrahi, et al.
The Journal of Infectious Diseases|April 15, 2010
Immunosuppressive treatments reduce long-term immunity to smallpox among patients with breast cancerItay Wiser, Nadav Orr, Bella Kaufman, et al.
The Pediatric Infectious Disease Journal|September 18, 2025
Shigella PCR-positive Gastroenteritis in Children: Insights From a Comparison Between Culture-positive and Culture-negative CasesYehonatan Beeri, Itamar Ben Shitrit, Guy Hazan, et al.
The Pediatric Infectious Disease Journal|February 16, 2013
Incidence and characteristics of sporadic norovirus gastroenteritis associated with hospitalization of children less than 5 years of age in IsraelKhitam Muhsen, Eias Kassem, Uri Rubinstein, et al.
Human Vaccines|May 8, 2010
Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: a case-control studyKhitam Muhsen, Lester Shulman, Eias Kasem, et al.
Emerging Infectious Diseases|March 27, 2015
Prevalence of hepatitis E virus antibodies, Israel, 2009-2010Orna Mor, Ravit Bassal, Michal Michaeli, et al.
NPJ Vaccines|March 9, 2023
A Shigella flexneri 2a synthetic glycan-based vaccine induces a long-lasting immune response in adultsShiri Meron-Sudai, Valeria Asato, Amos Adler, et al.
Pageof 12